AI as a new paradigm for risk-based screening for breast cancer

Field	Value	Language
dc.contributor.author	Houssami, Nehmat
dc.contributor.author	Kerlikowske, Karla
dc.date.accessioned	2023-03-20T00:16:13Z
dc.date.available	2023-03-20T00:16:13Z
dc.date.issued	2022	en
dc.identifier.uri	https://hdl.handle.net/2123/30238
dc.description.abstract	AI may represent a new tool in the risk assessment and screening pathway of breast cancer. To realise its potential, the effect of AI-supported decisions on relevant clinical outcomes must be prospectively evaluated.	en
dc.language.iso	en	en
dc.publisher	Nature research	en
dc.relation.ispartof	Nature Medicine	en
dc.rights	Copyright All Rights Reserved	en
dc.subject	cancer	en
dc.subject	population screening	en
dc.title	AI as a new paradigm for risk-based screening for breast cancer	en
dc.type	Article, Letter	en
dc.identifier.doi	10.1038/s41591-021-01649-3
dc.type.pubtype	Publisher's version	en
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Health	en
usyd.citation.volume	28	en
usyd.citation.spage	29	en
usyd.citation.epage	30	en
workflow.metadata.only	Yes	en

Associated file/s

There are no files associated with this item.